Skip to main content
. Author manuscript; available in PMC: 2021 Jul 15.
Published in final edited form as: Br J Haematol. 2018 Dec 5;184(5):744–752. doi: 10.1111/bjh.15702

FIGURE 1: Survival Experience, Phase I/II.

FIGURE 1:

Kaplan-Meier estimates of overall survival (OS) and progression-free survival (PFS) of 32 patients included in the survival analysis. The median PFS and OS was 2.98 months and 22.4 months, respectively.